icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Paris France
11-15 April 2018
Back grey_arrow_rt.gif
 
 
 
Efficacy and Safety of Elbasvir/Grazoprevir in Women Infected With Hepatitis C Virus Genotypes 1 or 4 and Coadministered Oral Contraceptives or Hormone Replacement Therapy
 
 
  Reported by Jules Levin
EASL 2018 April 11-15 Paris France
 
Hezode C1; Kwo P2; Sperl J3; Dore G4; Hwang P5; Long J5; Yeh W5; Talwani R5; Robertson M5; Haber B5 1Service d'Hépatologie, Hôpital Henri-Mondor, AP-HP, Université Paris-Est, INSERM U955, Créteil, France; 2Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA; 3Institute for Clinical and Experimental Medicine, Prague, Czech Republic; 4The Kirby Institute, University of New South Wales, Sydney, NSW, Australia; 5Merck & Co., Inc., Kenilworth, NJ, USA

0420181

0420182

0420183

0420184

0420185

0420186

0420187

0420188

0420189